Literature DB >> 18952706

Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care.

Satoshi Ishikura1.   

Abstract

The process of radiotherapy (RT) is complex and involves understanding of the principles of medical physics, radiobiology, radiation safety, dosimetry, radiation treatment planning, simulation and interaction of radiation with other treatment modalities. Each step in the integrated process of RT needs quality control and quality assurance (QA) to prevent errors and to give high confidence that patients will receive the prescribed treatment correctly. Recent advances in RT, including intensity-modulated and image-guided RT, focus on the need for a systematic RTQA program that balances patient safety and quality with available resources. It is necessary to develop more formal error mitigation and process analysis methods, such as failure mode and effect analysis, to focus available QA resources optimally on process components. External audit programs are also effective. The International Atomic Energy Agency has operated both an on-site and off-site postal dosimetry audit to improve practice and to assure the dose from RT equipment. Several countries have adopted a similar approach for national clinical auditing. In addition, clinical trial QA has a significant role in enhancing the quality of care. The Advanced Technology Consortium has pioneered the development of an infrastructure and QA method for advanced technology clinical trials, including credentialing and individual case review. These activities have an impact not only on the treatment received by patients enrolled in clinical trials, but also on the quality of treatment administered to all patients treated in each institution, and have been adopted globally; by the USA, Europe and Japan also.

Entities:  

Mesh:

Year:  2008        PMID: 18952706     DOI: 10.1093/jjco/hyn112

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  20 in total

1.  Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 study.

Authors:  Yasuo Hamamoto; Junki Mizusawa; Hiroshi Katayama; Kenichi Nakamura; Ken Kato; Yasuhiro Tsubosa; Satoshi Ishikura; Hiroyasu Igaki; Masayuki Shinoda; Haruhiko Fukuda; Yuko Kitagawa; Nobutoshi Ando
Journal:  Jpn J Clin Oncol       Date:  2016-01-31       Impact factor: 3.019

2.  Improving radiation oncology through clinical audits: Introducing the IROCA project.

Authors:  Maria Glòria Torras; Magdalena Fundowicz; Luisa Aliste; Esther Asensio; Anna Maria Boladeras; Josep Maria Borràs; Luísa Carvalho; Carla Castro; Letizia Deantonio; Ewelina Konstanty; Marco Krengli; Marta Kruszyna; Joana Lencart; Miquel Macià; Susanna Marín; Carles Muñoz-Montplet; Carla Pisani; Diana Pinto; Montserrat Puigdemont; Ferran Guedea; Artur Aguiar; Piotr Milecki; Julian Malicki
Journal:  Rep Pract Oncol Radiother       Date:  2017-08-11

3.  Multi-system verification of registrations for image-guided radiotherapy in clinical trials.

Authors:  Yunfeng Cui; James M Galvin; William L Straube; Walter R Bosch; James A Purdy; X Allen Li; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-13       Impact factor: 7.038

Review 4.  What we have learned: the impact of quality from a clinical trials perspective.

Authors:  Thomas J FitzGerald
Journal:  Semin Radiat Oncol       Date:  2012-01       Impact factor: 5.934

5.  Predictive time-series modeling using artificial neural networks for Linac beam symmetry: an empirical study.

Authors:  Qiongge Li; Maria F Chan
Journal:  Ann N Y Acad Sci       Date:  2016-09-14       Impact factor: 5.691

6.  Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis.

Authors:  André N Abrunhosa-Branquinho; Raquel Bar-Deroma; Sandra Collette; Enrico Clementel; Yan Liu; Coen W Hurkmans; Loïc Feuvret; Karen Van Beek; Martin van den Bent; Brigitta G Baumert; Damien C Weber
Journal:  Radiother Oncol       Date:  2018-03-29       Impact factor: 6.280

7.  A survey of the practice and management of radiotherapy linear accelerator quality control in the UK.

Authors:  A Palmer; J Kearton; O Hayman
Journal:  Br J Radiol       Date:  2012-06-06       Impact factor: 3.039

8.  Palliative care in enugu, Nigeria: challenges to a new practice.

Authors:  Tonia C Onyeka
Journal:  Indian J Palliat Care       Date:  2011-05

9.  A multi-national report on methods for institutional credentialing for spine radiosurgery.

Authors:  Peter C Gerszten; Arjun Sahgal; Jason P Sheehan; Ronald Kersh; Stephanie Chen; John C Flickinger; Mubina Quader; Daniel Fahim; Inga Grills; John H Shin; Brian Winey; Kevin Oh; Reinhart A Sweeney; Matthias Guckenberger
Journal:  Radiat Oncol       Date:  2013-06-27       Impact factor: 3.481

10.  Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centres.

Authors:  Carla Lopes de Castro; Magdalena Fundowicz; Alvar Roselló; Josep Jové; Letizia Deantonio; Artur Aguiar; Carla Pisani; Salvador Villà; Anna Boladeras; Ewelina Konstanty; Marta Kruszyna-Mochalska; Piotr Milecki; Diego Jurado-Bruggeman; Joana Lencart; Ignasi Modolell; Carles Muñoz-Montplet; Luisa Aliste; Maria Gloria Torras; Montserrat Puigdemont; Luísa Carvalho; Marco Krengli; Ferran Guedea; Julian Malicki
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.